Changes in BDNF levels and signaling pathways have been identified in several neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease, and have been linked with the symptoms and course of these diseases. The gene discussed is BDNF; the disease is early-onset autosomal dominant Alzheimer disease.